The drug VX-950 is an oral inhibitor of the hep c protease. This
protease is much needed for viral replication. This drug shows it has
the ability to slow and perhaps stop replication of hcv. 750 mg. every 8
hours. Go online and enter VX-950. Much more studies are to be done. One

This is a email I received from the Company today about the results of
their phase II trials.    Ron,
We expect to present data from the phase IIb trial of NM283 in
treatment refractory patients at AASLD this November.

http://www.forbes.com/lifestyle/health/feeds/hscout/2005/08/30/hscout527621.html